Advertisement

2023 Q2 Advocacy Update

|July 10, 2023

2023 Q2 Advocacy Update

The Advocacy Council continues its work – independently and with our various like-minded coalitions — on important issues that affect the allergy specialty, allergy practices and allergists. Some highlights of work during the second quarter of 2023 include:

Support for:

  • The AMA’sPhysician Practice Information Survey– the College encourages those who receive it to complete it. The practice-cost data collected will be used to advocate in support of physicians to accurately represent their practice, patients, and profession.
  • Requests forpediatric subspecialty loan forgivenessfor pediatricians practicing in underserved areas.
  • H.R. 2474:Strengthening Medicare for Patients and Providers Act– Thelegislationapplies a permanent inflation-based update to the Medicare Physician Fee Schedule (MPFS) conversion factor, which will provide much-needed stability to the Medicare payment system as our members contend with an increasingly challenging environment providing Medicare beneficiaries with access to timely and quality care.
  • The review of requirements forEmergency Medical Kitsin airplanes at least every three years with the goal of getting epinephrine autoinjectors placed in the kits.
  • Advancing Rural Care – establishesstudent loan repayment programs through HRSAto incentivize specialty health care providers, including Allergy/Immunology physicians, to practice in rural areas. Physicians would qualify after six years of practice in rural communities.
  • Team-based care– supporting the care of patients by a physician-led care team.

The College scored a big win when the Collegeadvocated for and won an allergy exception to USP Chapter 797. Permission has been granted from USP to publish this exception to Section 21 – Compounding Allergenic Extracts Exception – for our members. College members have exclusive access to our easy-to-read summary of the exception, which is available in ourAllergen Extract Mixing Toolkit.

The Advocacy Council also advocated for:

  • Theaddition of “allergists” to the list of supervising physicians in Ohio H.B. 102– Licensed Advanced Practice Respiratory Therapists.
  • CIGNA to revise its policy on Modifier 25. The Advocacy Council successfullyadvocated for this important issuewith other health care organizations.
  • Antimicrobial resistanceto be included in the Pandemic and All Hazards Preparedness Act.
  • Continuing support ofMedicare Payment Reform. The Advocacy Council continues toadvocate for legislation to correct physician reimbursement payments.
  • Standardizing prior authorizationand reducing administrative burdens.
  • ReducingGood Faith Estimateburdens.

宣传委员会也joined theFood Labeling Modernization Act stakeholders’ group.

表示公司全年工作仍在继续llege members to the government, regulatory bodies, and payers. The Advocacy Council – ADVOCATING FOR ALLERGISTS AND THEIR PATIENTS.

Advertisement